Abacus Life, Inc. (ABL) closed the last trading session at $8.86, gaining 0.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $14.13 indicates a 59.5% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $1.31. While the lowest estimate of $13 indicates a 46.7% increase from the current price level, the most optimistic analyst exp ...